BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
26 hedge funds and large institutions have $9.23M invested in BRAINSTORM CELL THERAPUTC in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
26
Holding in Top 10
–
Calls
$253K
Puts
–
Top Buyers
| 1 | +$2.76M | |
| 2 | +$1.66M | |
| 3 | +$471K | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$87K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$73.4K |
Top Sellers
| 1 | -$221K | |
| 2 | -$177K | |
| 3 | -$74K | |
| 4 |
GCA
Guardian Capital Advisors
Toronto,
Ontario, Canada
|
-$41K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$14.6K |